Study: Not all iron supplements for pregnant women should be “considered equal”

By Olivia Haslam

- Last updated on GMT

GettyImages - Pregnancy supplements / damircudic
GettyImages - Pregnancy supplements / damircudic

Related tags Iron Iron deficiency anemia Hemoglobin Iron deficiency Iron supplements Pregnancy iron status

A new systematic review and meta-analysis conducted by supplement manufacturer Balchem concludes ferrous bisglycinate supplementation in pregnant women results in improved haemoglobin status and a 64% lower rate of side effects compared to other iron salts.

Iron deficiency is a worldwide issue and is estimated to affect over 40% of women​ of childbearing age in certain countries.

A primary nutritional role of iron is to support erythropoiesis​, the body's process of making red blood cells.

When the body has a limited supply of iron, it directs that iron primarily to the production and maintenance of red blood cells​, prioritising that over all other systems, including those involved in developing the foetus. 

Iron salts such as ferrous sulphate are commonly provided as oral supplements to prevent and treat iron deficiency​.  

However many consumers are reluctant to take iron supplements during pregnancy as they often cause side-effects to the digestive system​, such as discomfort, constipation or diarrhoea.

Ferrous bisglycinate is a novel amino acid iron chelate that is thought to be more bioavailable and associated with fewer GI adverse events​ as compared with iron salts.

Ferrochel is a fully chelated iron formed by binding iron to two organic glycine molecules, designed to utilise its small molecular size to remain intact throughout the GI tract for optimal absorption.

According to Balchem, this more bioavailable form of iron is essential for  pregnant women and growing children. 

The study

The authors of the current study conducted a systematic search of electronic databases up to July 2020, yielding 17 randomised controlled trials (RCTs) which focused on over 1,100 children and pregnant women. 

All RCTS included in the study reported haemoglobin or ferritin concentrations following at least 4 weeks' supplementation of ferrous bisglycinate compared with other iron supplements in any dose or frequency. 

Random-effects meta-analyses were conducted among trials of pregnant women (n = 9) and children (n = 4); pooled estimates were expressed as standardised mean differences (SMDs). 

Incidence rate ratios (IRRs) were estimated for GI adverse events, using Poisson generalised linear mixed-effects models.

Compared with other iron supplements, supplementation with ferrous bisglycinate for 4-20 weeks resulted in higher haemoglobin concentrations in pregnant women (SMD, 0.54 g/dL; 95% confidence interval [CI], 0.15-0.94; P < 0.01) and fewer reported GI adverse events (IRR, 0.36; 95%CI, 0.17-0.76; P < 0.01).

Crystal Karakochuk, lead researcher on the study, states: “These findings are important as they confirm that not all oral iron supplements should be considered as equal. The ideal form of iron in prenatal multiple micronutrients should be highly bioavailable and have a low risk of gastrointestinal side effects to optimise adherence and reduce the risk of iron deficiency anaemia during pregnancy. 

“Ultimately, our findings show promise for ferrous bisglycinate as a superior form of supplemental iron compared to iron salts.”

Further research

Following this initial study, Balchem has now commissioned a new clinical trial on Ferrochel​ in pregnant women with the same research team, which aims to begin recruitment in Autumn 2023. 

This research aims to provide further insights into the optimal forms of iron to be used across various ages and stages of life.


Journal: Nutrition Reviews

“The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomized controlled trials.”

Authors: Jordie A J Fischer, Arlin M Cherian, Jeffrey N Bone, and Crystal D Karakochuk.

Related topics Research Maternal & infant health

Related news

Related products

Latest Research Findings on Omega-3s for Heart Health

Latest Research Findings on Omega-3s for Heart Health

Content provided by GC Rieber VivoMega™ | 12-Feb-2024 | White Paper

According to Grandview Research, the global omega-3 market is a $2.62 billion market and is one of the fastest-growing segments in the dietary supplement...

Kaneka Ubiquinol® and Preconception Health

Kaneka Ubiquinol® and Preconception Health

Content provided by Kaneka Nutrients – Manufacturer and Supplier of Kaneka Ubiquinol® | 02-Feb-2024 | White Paper

An ally in the fight against oxidative stress, Kaneka Ubiquinol® offers antioxidant support for men and women concerned about reproductive health.

Related suppliers

Follow us


View more